Skip to content

Montelukast EP Impurity D

Montelukast EP Impurity D

Product Description
CAT No.
ALN-M031024
CAS No.
1187586-61-3
Mol. F.
C41H46ClNO5S2
Mol. Wt.
732.4
Stock
Please Inquire
Chemical Name : 1-[[[(1R)-1-[3-[(1R)-1-[[[1-(carboxymethyl)cyclopropyl]methyl]sulfanyl]-2-(7-chloroquinolin-2-yl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetic acid (as per EP); 1-[[[(1R)-1-[3-[(1R)-1-[[[1-(Carboxymethyl)cyclopropyl]methyl]sulfanyl]-2-(7-chloroquinolin-2-yl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetic acid (as per USP)
Smiles : CC(C1=CC=CC=C1CC[C@@H](SCC2(CC2)CC(O)=O)C3=CC=CC([C@H](SCC4(CC4)CC(O)=O)CC5=NC6=CC(Cl)=CC=C6C=C5)=C3)(C)O
Inchi : InChI=1S/C35H34ClNO2S/c1-24(2)31-9-4-3-7-26(31)13-17-33(40-23-35(18-19-35)22-34(38)39)28-8-5-6-25(20-28)10-15-30-16-12-27-11-14-29(36)21-32(27)37-30/h3-12,14-16,20-21,33H,1,13,17-19,22-23H2,2H3,(H,38,39)/b15-10+/t33-/m1/s1
Synonym : Montelukast Michael Adduct (R,R)-Isomer (USP)

Method development and validation for the simultaneous estimation of montelukast and acebrophylline in bulk and tablet dosage forms by RP-HPLC

By Ankitha, M.; Ashitha, S.; Sri, Ragasudha A.; Latha, Madhavi P. V.; Devi, Uma P.nFrom Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9173-9179

Montelukast microsuspension with hypromellose for improved stability and oral absorption

By Lee, Ha Ryeong; Park, Hyun Jin; Park, Jun Soo; Park, Dong Woo; Ho, Myoung Jin; Kim, Dong Yoon; Lee, Hyo Chun; Kim, Eun Jeong; Song, Woo Heon; Park, Jun Sang; et al – From International Journal of Biological Macromolecules (2021), 183, 1732-1742

Analytical method development and validation for simultaneous estimation of Bilastine and Montelukast sodium by UV spectrophotometry

By Raj, R. Mohan; Sankar, A. S. K.; Vetrichelvan, T. – From World Journal of Pharmacy and Pharmaceutical Sciences (2021), 10(1), 680-687

Request For Quotation